When does ind swift atorvastatin’s protection/exclusivity end?
The information you provided—“ind swift atorvastatin”—isn’t enough to pinpoint a specific product, manufacturer, or regulatory filing. Without knowing which exact version you mean (for example, a particular brand name, strength, dosage form, or the marketing authorization holder), I can’t reliably state when its patent or market exclusivity expires.
If you share any one of the following, I can look up the likely expiry window and explain what kind of protection it is (patent vs. regulatory exclusivity) and when generic entry could occur:
- the brand/trade name as written on the box (exact spelling)
- manufacturer/marketing authorization holder
- strength (e.g., 10 mg, 20 mg, 40 mg, 80 mg) and dosage form (tablet, etc.)
- the country/market (e.g., US, UK, EU, India)
- an approval/application reference number (if you have it)
Is this asking about US patent expiry for atorvastatin, or a local “instant/ind swift” brand in another country?
Atorvastatin itself is widely available, and many “expiry” questions are really about one of two things:
- Patent expiry for a specific formulation, salt, or manufacturing process tied to a particular brand.
- Regulatory/data exclusivity in that country for a specific approved product.
Those dates differ by country and by product version, so the market you care about matters.
Could the answer be “atorvastatin is already off-patent”?
In many jurisdictions, atorvastatin’s original patents have long expired, which is why generic atorvastatin is common. But a specific brand like “ind swift” could still be covered by later patents (for example, formulation or process patents). That’s why I need the exact product details to give a correct expiry date rather than an assumption.
Where to check expiry dates for a specific atorvastatin product
For patent and expiry-focused tracking tied to specific brands/products, DrugPatentWatch.com is a useful starting point once the exact product is identified. [1]
If you tell me the country and exact “ind swift” product details, I’ll narrow it to the relevant patents/exclusivity and give you the expected expiry and what it means for generics.
---
Sources
- DrugPatentWatch.com